Archive for the ‘Events’ Category

Inaugural Medicine by Design Symposium – Engineering progress in regenerative medicine

Author: Nicole Forgione, 12/21/16

On November 28 local and international leaders of the regenerative medicine (RM) community gathered at the MaRS Centre in Toronto for the first ever Medicine by Design (MbD) Symposium. The event marked the first year of the MbD program at the University of Toronto (U of T). This initiative was established based on a $114…Read more

Right Turn: The elements of a great story (courtesy of OIRM’s SciComms Workshop)

Author: Laine Jaremey, 12/16/16

I joined graduate students and early-career researchers at OIRM’s first Science Communications Workshop, held November 24, 2016 in Toronto. Expert communicators from a variety of backgrounds provided a valuable introduction to the essentials of successful science communication at the day-long event. We learned that storytelling is a tool that can help you to construct compelling…Read more

Understanding how to hone your story for media – Tips from an expert

Author: Laine Jaremey, 12/13/16

Last month, the Ontario Institute for Regenerative Medicine (OIRM) hosted its first Science Communications Workshop. Expert speakers, who included journalists, communicators and social media specialists, educated the mostly graduate students and early-career researchers in attendance by helping them navigate media interviews and communicate their work using social media. In this post, I’m sharing learnings from…Read more

Right Turn: WSCS has something for everyone, under the Florida sun

Author: Stacey Johnson, 12/09/16

Have you been to the World Stem Cell Summit before? This meeting bills itself as the “original, translation-focused global meeting of stakeholders” that brings together leading scientists and clinicians, investors, customers, legal experts, funders, regulators and patients in the regenerative medicine field. And it’s all true. It’s a four-day cornucopia featuring 90 hours of programming…Read more

Insights from CGTW16 – Part 3: Clinical trials, health economics and regulatory affairs

Author: Guest, 12/01/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Insights from CGTW16 – Part 2: scale-up challenges and closed systems

Author: Guest, 11/23/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Insights from CGTW16 – Part 1: Cell Manufacturing Best Practices

Author: Guest, 11/17/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Making connections – advancing regenerative medicine through partnerships

Author: Nicole Forgione, 11/08/16

A key driver for advancements in regenerative medicine is partnerships. In recognition of this, every year CCRM hosts a networking reception that brings together our partners for an evening of discussion and knowledge sharing. This year’s industry networking reception was focused on the theme of increasing partnerships between industry and academia. I had the privilege…Read more

Ending on a high note – Day 3 of TMM2016

Author: Camila Londono, 10/31/16

Though the last day of the Till and McCulloch Meetings was a short one, it was absolutely fantastic. The day began with a thought-provoking talk by Douglas Sipp, from the Riken Center for Developmental Biology, touching upon the many issues surrounding regulation of stem cell therapies. I think as scientists, we often tend to forget…Read more

Lobbying for deregulation of stem cell procedures is giving rise to a new “dark economy”

Author: Hamideh Emrani, 10/31/16

Day 3 of the Till & McCulloch Meetings continued with many interesting talks. The one that I have chosen to write about in more detail Dr. Douglas Sipp’s, titled “The Stem Cell Dark Economy.” I think his talk was really thought provoking, and important to be shared with our readers. He began with an old…Read more